Isoptin

Verapamil, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral dosage form for systemic use. It is employed to manage high blood pressure, relieve chest pain from angina, and control certain rapid heart rhythms in adult patients. GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin (verapamil) acts on the cardiovascular system to modify calcium influx, which influences blood pressure and cardiac rhythm. - Hypertension: lowers systemic blood pressure by causing peripheral vasodilation. - Angina pectoris: reduces myocardial oxygen demand by decreasing heart rate and contractility, relieving chest pain. - Supraventricular tachyarrhythmias: slows atrioventricular‑node conduction, helping to restore normal heart rhythm in conditions such as atrial fibrillation or flutter.

Verapamil may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Dizziness or light‑headedness: related to blood pressure lowering. - Headache: often transient during initiation. - Peripheral edema: fluid accumulation in lower limbs.

Serious or Rare Side Effects: - Bradycardia: markedly slowed heart rate requiring medical attention. - Hypotension: significant drop in blood pressure that can cause fainting. - AV‑block or other conduction disturbances: may necessitate discontinuation or pacing.

Before initiating verapamil therapy, clinicians should consider several safety measures. - Monitor blood pressure: ensure adequate control without excessive hypotension. - Assess cardiac function: evaluate for existing heart block or severe heart failure. - Use caution in patients with hepatic impairment: dose adjustments may be needed. - Avoid abrupt discontinuation: taper to prevent rebound hypertension or tachycardia. - Review concomitant medications: check for interactions that could amplify cardiac effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Verapamil interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Beta‑blockers: combined use can cause profound bradycardia or AV‑block. - Digoxin: verapamil raises digoxin serum levels, increasing toxicity risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may markedly increase verapamil exposure.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): can reduce therapeutic effect. - Other antihypertensives (e.g., ACE inhibitors, diuretics): additive blood‑pressure lowering. - Lithium: verapamil may raise lithium concentrations, necessitating serum level monitoring.